The report analyzes and forecasts the antibacterial drugs market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
This report first introduces the background of antibacterial drugs, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major antibacterial drugs companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of antibacterial drugs upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of antibacterial drugs and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global antibacterial drugs market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the antibacterial drugs market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of antibacterial drugs market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Competitive Outlook
This report also includes various ups and downs about particular country or geography that has impacted the overall market globally. The report provides a detailed outline/blueprint of the antibacterial drugs market globally that will assist new companies in establishing their presence and market players in expanding their market share in the market. The report concludes with the company profile section which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies and recent developments for market players. Prominent key players are Bayer AG, Pfizer Inc., Sanofi, GlaxoSmithKline Plc. (GSK), Merck & Co., Inc., AstraZeneca, Johnson and Johnson, Bristol Myers Squibb Company, Novartis AG, and Allergen plc
Global antibacterial drugs market is segmented as given below:
Global Antibacterial Drugs Market, by Drug Class
Global Antibacterial Drugs Market, by Routes of Administration
Global Antibacterial Drugs Market, by Distribution Channel
Global Antibacterial Drugs Market, by Geography
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
Chapter 1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Assumptions and Acronyms Used
Chapter 2. Research Methodology
Chapter 3. Executive Summary
Chapter 4. Market Overview
4.1. Product Overview
4.2. Key Industry Developments
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity Analysis
4.3.4. Porter’s Five Forces Representation
4.3.5. Antibacterial Drugs Market- Value Chain Analysis & Supply-Demand Scenario
4.3.6. Antibacterial Drugs Market Outlook
4.3.7. Anti-Bacterial Drugs Pipeline Analysis
Chapter 5. Global Antibacterial Drugs Market Analysis, by Drug Class, 2015 – 2026
5.1. Key Findings
5.2. Definition
5.3. Introduction
5.4. Global Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2017 and 2026
5.5. Global Antibacterial Drugs Market Analysis, by Drug Class
5.5.1. β-lactam
5.5.2. Quinolones
5.5.3. Macrolides
5.5.4. Tetracycline
5.5.5. Aminoglycoside
5.5.6. Sulfonamide
5.5.7. Phenicols
5.5.8. Others
5.6. Global Antibacterial Drugs Market Attractiveness Analysis, by Drug Class
5.7. Global Antibacterial Drugs Market Forecast, by Drug Class
5.8. Key Trends
Chapter 6. Global Antibacterial Drugs Market Analysis, by Routes of Administration
6.1. Key Findings
6.2. Definitions
6.3. Introduction
6.4. Global Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2017 and 2026
6.5. Global Antibacterial Drugs Market Analysis, by Routes of Administration
6.5.1. Enteral
6.5.2. Parenteral
6.5.3. Others
6.6. Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration
6.7. Global Antibacterial Drugs Market Forecast, by Routes of Administration
Chapter 7. Global Antibacterial Drugs Market Analysis, by Channels of Distribution
7.1. Key Findings
7.2. Definitions
7.3. Introduction
7.4. Global Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2017 and 2026
7.5. Global Antibacterial Drugs Market Analysis, by Channels of Distribution
7.5.1. Hospital Pharmacies
7.5.2. Drug Stores & Retail Pharmacies
7.5.3. Online Sales
7.6. Global Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution
7.7. Global Antibacterial Drugs Market Forecast, by Channels of Distribution
7.8. Key Trends
Chapter 8. Global Antibacterial Drugs Market Analysis, by Region
8.1. Key Findings
8.2. Introduction
8.3. Global Antibacterial Drugs Market Value Share Analysis, by Region, 2017 and 2026
8.4. Global Antibacterial Drugs Market Attractiveness Analysis, by Region, 2017
8.5. Global Antibacterial Drugs Market Forecast, by Region, 2015–2026
Chapter 9. North America Antibacterial Drugs Market Analysis
9.1. North America Antibacterial Drugs Market Overview
9.2. North America Antibacterial Drugs Market Forecast, Country wise, 2015–2026
9.3. North America Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2017 and 2026
9.4. North America Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2017
9.5. North America Antibacterial Drugs Market Forecast, by Drug Class, 2015–2026
9.6. North America Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2017 and 2026
9.7. North America Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2017
9.8. North America Antibacterial Drugs Market Forecast, by Routes of Administration, 2015–2026
9.9. North America Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2017 and 2026
9.10. North America Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2017
9.11. North America Antibacterial Drugs Market Forecast, by Channels of Distributions, 2015–2026
9.12. Key Trends
Chapter 10. Europe Antibacterial Drugs Market Analysis
10.1. Europe Antibacterial Drugs Market Overview
10.2. Europe Antibacterial Drugs Market Forecast, Country wise, 2015–2026
10.3. Europe Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2017 and 2026
10.4. Europe Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2017
10.5. Europe Antibacterial Drugs Market Forecast, by Drug Class, 2015–2026
10.6. Europe Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2017 and 2026
10.7. Europe Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2017
10.8. Europe Antibacterial Drugs Market Forecast, by Routes of Administration, 2015–2026
10.9. Europe Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2017 and 2026
10.10. Europe Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2017
10.11. Europe Antibacterial Drugs Market Forecast, by Channels of Distributions, 2015–2026
10.12. Key Trends
Chapter 11. Asia Pacific Antibacterial Drugs Market Analysis
11.1. Asia Pacific Antibacterial Drugs Market Overview
11.2. Asia Pacific Antibacterial Drugs Market Forecast, Country wise, 2015–2026
11.3. Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2017 and 2026
11.4. Asia Pacific Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2017
11.5. Asia Pacific Antibacterial Drugs Market Forecast, by Drug Class, 2015–2026
11.6. Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2017 and 2026
11.7. Asia Pacific Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2017
11.8. Asia Pacific Antibacterial Drugs Market Forecast, by Routes of Administration, 2015–2026
11.9. Asia Pacific Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2017 and 2026
11.10. Pacific Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2017
11.11. Asia Pacific Antibacterial Drugs Market Forecast, by Channels of Distributions, 2015–2026
11.12. Key Trends
Chapter 12. Latin America Antibacterial Drugs Market Analysis
12.1. Latin America Antibacterial Drugs Market Overview
12.2. Latin America Antibacterial Drugs Market Forecast, Country wise, 2015–2026
12.3. Latin America Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2017 and 2026
12.4. Latin America Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2017
12.5. Latin America Antibacterial Drugs Market Forecast, by Drug Class, 2015–2026
12.6. Latin America Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2017 and 2026
12.7. Latin America Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2017
12.8. Latin America Antibacterial Drugs Market Forecast, by Routes of Administration, 2015–2026
12.9. Latin America Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2017 and 2026
12.10. Latin America Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2017
12.11. Latin America Antibacterial Drugs Market Forecast, by Channels of Distributions, 2015–2026
12.12. Key Trends
Chapter 13. Middle East & Africa Antibacterial Drugs Market Analysis
13.1. Middle East & Africa Antibacterial Drugs Market Overview
13.2. Middle East & Africa Antibacterial Drugs Market Forecast, Country wise, 2015–2026
13.3. Middle East & Africa Antibacterial Drugs Market Value Share Analysis, by Drug Class, 2017 and 2026
13.4. Middle East & Africa Antibacterial Drugs Market Attractiveness Analysis, by Drug Class, 2017
13.5. Middle East & Africa Antibacterial Drugs Market Forecast, by Drug Class, 2015–2026
13.6. Middle East & Africa Antibacterial Drugs Market Value Share Analysis, by Routes of Administration, 2017 and 2026
13.7. Middle East & Africa Antibacterial Drugs Market Attractiveness Analysis, by Routes of Administration, 2017
13.8. Middle East & Africa Antibacterial Drugs Market Forecast, by Routes of Administration, 2015–2026
13.9. Middle East & Africa Antibacterial Drugs Market Value Share Analysis, by Channels of Distribution, 2017 and 2026
13.10. Middle East & Africa Antibacterial Drugs Market Attractiveness Analysis, by Channels of Distribution, 2017
13.11. Middle East & Africa Antibacterial Drugs Market Forecast, by Channels of Distributions, 2015–2026
13.12. Key Trends
Chapter 14. Competition Landscape
14.1. Leading Antibacterial Drugs Sales Analysis, 2014 – 2017
14.2. Competition Matrix
14.3. Company Profiles
14.3.1. Bayer AG
14.3.1.1. Company Description
14.3.1.2. Business Overview
14.3.1.3. SWOT Analysis
14.3.1.4. Strategic Overview
14.3.2. Pfizer Inc.
14.3.2.1. Company Description
14.3.2.2. Business Overview
14.3.2.3. SWOT Analysis
14.3.2.4. Strategic Overview
14.3.3. Sanofi
14.3.3.1. Company Description
14.3.3.2. Business Overview
14.3.3.3. SWOT Analysis
14.3.3.4. Strategic Overview
14.3.4. GlaxoSmithKline plc
14.3.4.1. Company Description
14.3.4.2. Business Overview
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. Merck & Co., Inc
14.3.5.1. Company Description
14.3.5.2. Business Overview
14.3.5.3. SWOT Analysis
14.3.5.4. Strategic Overview
14.3.6. AstraZeneca
14.3.6.1. Company Description
14.3.6.2. Business Overview
14.3.6.3. SWOT Analysis
14.3.6.4. Strategic Overview
14.3.7. Johnson and Johnson
14.3.7.1. Company Description
14.3.7.2. Business Overview
14.3.7.3. SWOT Analysis
14.3.7.4. Strategic Overview
14.3.8. Bristol-Myers Squibb Company
14.3.8.1. Company Description
14.3.8.2. Business Overview
14.3.8.3. SWOT Analysis
14.3.8.4. Strategic Overview
14.3.9. Novartis AG
14.3.9.1. Company Description
14.3.9.2. Business Overview
14.3.9.3. SWOT Analysis
14.3.9.4. Strategic Overview
14.3.10. Allergen Plc.
14.3.10.1. Company Description
14.3.10.2. Business Overview
14.3.10.3. SWOT Analysis
14.3.10.4. Strategic Overview
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers